A1 Journal article – refereed

Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study

List of Authors: Ryhänen Eeva M, Koski Anna Mari, Löyttyniemi Eliisa, Välimäki Matti Juhani, Kiviniemi Ulla, Schalin-Jäntti Camilla


Publication year: 2021

Journal: European Journal of Endocrinology


Journal acronym: EUR J ENDOCRINOL

Volume number: 185

Issue number: 4

Number of pages: 10

ISSN: 0804-4643

eISSN: 1479-683X

DOI: http://dx.doi.org/10.1530/EJE-21-0322


Objective: In primary hyperparathyroidism (PHPT) with osteoporosis, bone mineral density (BMD) improves after parathyroidectomy. It is unclear whether combining surgery with postoperative bisphosphonate treatment can further improve bone health.

Design: This randomized, placebo-controlled study compared the effects of surgery alone and surgery combined with zoledronic acid on bone metabolism in PHPT with osteoporosis.

Methods: Fifty-six patients (f/m 47/9, mean age 68.4 years) with PHPT and osteoporosis were randomized 1-3 months after parathyroidectomy to receive a 2-year treatment of zoledronic acid or placebo. Dual-energy X-ray absorptiometry (DXA) and bone turnover markers (N-terminal propeptide of type 1 procollagen, C-terminal telopeptide of type 1 collagen, and alkaline phosphatase) were measured annually during the 2-year follow-up.

Results: Two years after parathyroidectomy, BMD was significantly higher in the zoledronic acid (ZOL) group compared with the placebo (PBO) group at the femoral neck (P = 0.045 for Z-score) and lumbar spine (P = 0.039 and 0.017 for T-and Z-scores, respectively). Bone turnover markers were significantly lower in the ZOL group (P 0.001 for all markers). Of the 18 patients who had received bisphosphonates for 1 year before surgery, BMD improved significantly in the ZOL group both in the femoral neck and lumbar spine (n = 10; all P < 0.001-0.01), but in the PBO group, only in the lumbar spine (n = 8, P = 0.03), (P = 0.08-0.95 for between-group changes).

Conclusion: BMD increases after parathyroidectomy both with and without zoledronic acid but the increase is significantly higher with postoperative zoledronic acid.

Last updated on 2021-26-10 at 15:16